Marktprognose für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum bis 2030 – Regionale Analyse – nach Produkt (Reagenzien und Instrumente), Methode (virale Methoden, nicht-virale Methoden und Hybridmethoden), Anwendung (biomedizinische Forschung, Proteinproduktion und Therapeutikaverabreichung) und Endnutzer (Akademien und Forschungsinstitute sowie Pharma- und Biotechnologieunternehmen)
Wachsende wirtschaftliche Belastung durch Krebs beflügelt den Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum
Laut der Weltgesundheitsorganisation (WHO) ist Krebs eine der häufigsten Todesursachen weltweit und war im Jahr 2020 für etwa 10 Millionen Todesfälle verantwortlich. Laut der Internationalen Agentur für Krebsforschung wird die globale Krebsbelastung bis 2040 wahrscheinlich um 30,2 Millionen zusätzliche Fälle zunehmen. Laut der Brustkrebsorganisation sind etwa 5–10 % der Brustkrebsfälle weltweit erblich bedingt und werden durch abnormale Gene verursacht, die von Generation zu Generation weitergegeben werden. Laut dem Artikel „Lifestyle, Genetic Risk and Incidence of Cancer“, der 2023 im International Journal of Epidemiology veröffentlicht wurde, sind fast 33 % der auftretenden Krebserkrankungen erblich bedingt, und das Risiko genetischer Mutationen ist bei dieser Krankheit hoch. Daher entscheiden sich die Menschen für eine genetische Profilierung zur Früherkennung und personalisierten Behandlung von erblich bedingten Krebsfällen. BRCA1 und BRCA2 werden manchmal als Tumorsuppressorgene bezeichnet. Menschen, die die schädlichen Varianten eines dieser Gene erben, haben ein höheres Risiko für verschiedene Krebsarten, insbesondere Brust- und Eierstockkrebs. Diese Menschen neigen auch dazu, in jüngeren Jahren an Krebs zu erkranken als Menschen, die keine Variationen in den genannten Genen aufweisen. Studien, die sich auf die Verarbeitung von Nukleinsäure durch Krebszellen konzentrieren, werden wahrscheinlich dazu beitragen, den Krebsstoffwechsel zu verstehen. DNA wird typischerweise in ein virales oder nicht-virales Partikel verpackt, um in die zu transfizierende Zelle übertragen zu werden. Der Gentransfer wurde als neuer Ansatz vorgeschlagen, um die Wirksamkeit von Antitumormedikamenten bei der Behandlung hartnäckiger oder metastasierter Krebserkrankungen zu verbessern. Die Kombination von Gentherapie und Medikamenten (ähnliche Therapie) soll die antiproliferativen Effekte klassischer Behandlungen unter anderem bei Lungen-, Dickdarm-, Bauchspeicheldrüsen-, Blasen- und Brustkrebs verstärken. Somit stärkt die zunehmende wirtschaftliche Belastung durch Krebs den Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum.
Marktübersicht für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum
Die Region Asien-Pazifik ist in China, Japan, Indien, Südkorea, Australien und den Rest des asiatisch-pazifischen Raums unterteilt. China hält im Jahr 2022 den größten Marktanteil. Länder im asiatisch-pazifischen Raum wie China, Indien, Singapur und weitere verfügen über ein gut etabliertes Gesundheitssystem sowie eine schnell wachsende Pharma- und Medizinindustrie. Diese Länder verfügen über viele Gesundheitseinrichtungen, die Krebspatienten behandeln und betreuen. Einer NIH-Studie zufolge stieg die Zahl der jährlichen Patienteneinweisungen in Krebskrankenhäuser in China im Zeitraum 2010–2020 von 1,10 Millionen auf 3,24 Millionen. Laut einer 2023 im Journal of the American Medical Association veröffentlichten Studie liegt die Prävalenz chronischer Nierenerkrankungen (CKD) bei Menschen ab 18 Jahren in Festlandchina bei 8,2 %. Darüber hinaus zeigen die neuesten Daten der International Agency for Research on Cancer (IARC), dass die geschätzte altersstandardisierte Rate (ASR) für Magenkrebs in China 21 pro 100.000 beträgt und die Rohrate 33,06 beträgt; für Bauchspeicheldrüsenkrebs beträgt die ASR 5 pro 100.000 mit einer Rohrate von 8,6. Der gleichen Quelle zufolge betrug die geschätzte Zahl der Neuerkrankungen an Magenkrebs und Bauchspeicheldrüsenkrebs bei Menschen im Alter von 0–74 Jahren im Jahr 2020 (für beide Geschlechter) 478.508 bzw. 124.994. Somit treibt die hohe Belastung durch chronische Krankheiten die Nachfrage nach CGTs in China an, was wiederum das Wachstum des Marktes für Transfektionsreagenzien und -geräte ankurbelt.
Umsatz und Prognose für den Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum bis 2030 (in Mio. USD)
Segmentierung des Marktes für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum
Der Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum ist nach Produkt, Methode, Anwendung, Endbenutzer und Land segmentiert.
Basierend auf dem Produkt ist der Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum in Reagenzien und Instrumente unterteilt. Das Segment Reagenzien hatte 2022 einen größeren Anteil.
In Bezug auf die Methode ist der Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum in virale Methoden, nicht-virale Methoden und Hybridmethoden segmentiert. Das Segment nicht-virale Methoden hatte 2022 den größten Anteil. Das virale Segment ist in Retroviren, Adenoviren, Adeno-assoziierte Viren und Herpesviren unterteilt. Das nicht-virale Segment ist in physikalische/mechanische Methoden und chemische Methoden unterteilt. Darüber hinaus ist das Segment der physikalischen/mechanischen Methoden in Elektroporation, Mikroinjektion, biolistische Methode, Lasermethode, Magnetofektion und Sonoporation unterteilt. Auch das Segment der chemischen Methoden ist in liposomal/lipidreich und nicht liposomal/lipidreich unterteilt.
Nach Anwendung ist der Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum in biomedizinische Forschung, Proteinproduktion und Therapeutikaverabreichung unterteilt. Das Segment biomedizinische Forschung hatte 2022 den größten Anteil.
Basierend auf dem Endverbraucher ist der Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum in Hochschulen und Forschungsinstitute sowie Pharma- und Biotechnologieunternehmen unterteilt. Das Segment Hochschulen und Forschungsinstitute hatte 2022 einen größeren Anteil.
Nach Ländern ist der Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum in Australien, China, Indien, Japan, Südkorea und den Rest des asiatisch-pazifischen Raums unterteilt. China dominierte 2022 den Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum.
Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc und Polyplus-Transfection SA sind einige der führenden Unternehmen auf dem Markt für Transfektionsreagenzien und -geräte im asiatisch-pazifischen Raum.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 Asia Pacific Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - Asia Pacific Market Analysis
5.1 Asia Pacific Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 Asia Pacific Transfection Reagents and Equipment Market Forecast Analysis
6. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Transfection Reagents and Equipment Market -Country Analysis
10.1 Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1 Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1.1 China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 China: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.1.2 China: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.1.2.1 China: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.1.2.2 China: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.1.2.2.1 China: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.1.2.2.2 China: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.1.3 China: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.1.4 China: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.2 Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.2.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.2.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.2.2.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.2.2.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.2.3 Japan: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.2.4 Japan: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.3 India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 India: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.3.2 India: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.3.2.1 India: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.3.2.2 India: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.3.2.2.1 India: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.3.2.2.2 India: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.3.3 India: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.3.4 India: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.4 South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.4.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.4.2.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.4.2.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.4.2.2.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.4.2.2.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.4.3 South Korea: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.4.4 South Korea: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.5 Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.5.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.5.2.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.5.2.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.5.2.2.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.5.2.2.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.5.3 Australia: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.5.4 Australia: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.6 Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.6.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.6.2.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.6.2.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.6.2.2.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.6.2.2.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.6.3 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.6.4 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Mirus Bio LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lonza Group AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MaxCyte Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
List of Tables
Table 1. Asia Pacific Transfection Reagents and Equipment Market Segmentation
Table 2. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 37. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 38. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 39. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 40. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 41. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 42. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 43. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 44. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 45. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 46. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 47. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 48. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 49. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 50. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 51. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 52. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 53. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 54. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 55. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 56. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 57. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 58. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 59. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 60. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 61. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. Asia Pacific Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Asia Pacific: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 38. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 39. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 40. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.